AU1889000A - Composition comprising (+/-)-5-ethyldihydro-5-(1-methylbutyl)-2-thioxo 4,6(1H,5H)-pyrimidinedione dissolved in 2,5-DI-O-methyl-1,4:3,6-dianhydro-D-glucitol - Google Patents

Composition comprising (+/-)-5-ethyldihydro-5-(1-methylbutyl)-2-thioxo 4,6(1H,5H)-pyrimidinedione dissolved in 2,5-DI-O-methyl-1,4:3,6-dianhydro-D-glucitol

Info

Publication number
AU1889000A
AU1889000A AU18890/00A AU1889000A AU1889000A AU 1889000 A AU1889000 A AU 1889000A AU 18890/00 A AU18890/00 A AU 18890/00A AU 1889000 A AU1889000 A AU 1889000A AU 1889000 A AU1889000 A AU 1889000A
Authority
AU
Australia
Prior art keywords
ethyldihydro
dianhydro
pyrimidinedione
glucitol
thioxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU18890/00A
Inventor
Shashikant Prabhudas Kurani
Dinesh Shantilal Patel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU1889000A publication Critical patent/AU1889000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A61K31/515Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU18890/00A 1999-05-31 1999-09-14 Composition comprising (+/-)-5-ethyldihydro-5-(1-methylbutyl)-2-thioxo 4,6(1H,5H)-pyrimidinedione dissolved in 2,5-DI-O-methyl-1,4:3,6-dianhydro-D-glucitol Abandoned AU1889000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN407/BOM/99 1999-05-31
IN407BO1999 1999-05-31
PCT/IN1999/000048 WO2000072848A1 (en) 1999-05-31 1999-09-14 Composition comprising (±)-5-ethyldihydro-5-(1-methylbutyl)-2-thioxo 4,6(1h,5h)-pyrimidinedione dissolved in 2,5-di-o-methyl-1,4:3,6-dianhydro-d-glucitol

Publications (1)

Publication Number Publication Date
AU1889000A true AU1889000A (en) 2000-12-18

Family

ID=11079989

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18890/00A Abandoned AU1889000A (en) 1999-05-31 1999-09-14 Composition comprising (+/-)-5-ethyldihydro-5-(1-methylbutyl)-2-thioxo 4,6(1H,5H)-pyrimidinedione dissolved in 2,5-DI-O-methyl-1,4:3,6-dianhydro-D-glucitol

Country Status (2)

Country Link
AU (1) AU1889000A (en)
WO (1) WO2000072848A1 (en)

Also Published As

Publication number Publication date
WO2000072848A1 (en) 2000-12-07

Similar Documents

Publication Publication Date Title
AU2001258359A1 (en) Ir-absorbing compositions
AU6694600A (en) Cosmetic compositions with self-warming component
AU2078801A (en) Ink compositions
AU4318000A (en) Agarobiose-containing composition
AU6303800A (en) Improvements in or relating to polymers
AU1290501A (en) Composition
AU5622300A (en) Stable l-ascorbic acid composition
AU2176001A (en) Cosmetic composition
AU2002223761A1 (en) Thickening composition
AU7789800A (en) Stable multiple emulsion composition
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof
AU1889000A (en) Composition comprising (+/-)-5-ethyldihydro-5-(1-methylbutyl)-2-thioxo 4,6(1H,5H)-pyrimidinedione dissolved in 2,5-DI-O-methyl-1,4:3,6-dianhydro-D-glucitol
AU2623500A (en) Water based metal working composition
AU2001263511A1 (en) Alkyl glycidyl carbonate compositions and their preparation
AU6310600A (en) Composition
AU1041801A (en) Improvements in or relating to an infuser
AUPQ052399A0 (en) Ball mill
AU3220600A (en) Modacrylic copolymer composition
AU6866400A (en) Bleacher composition
AU1766101A (en) Effervescent histamine H2 antagonist composition
AU5567600A (en) Hairdye composition
AU5078700A (en) Novel composition
AU6610500A (en) Antidiscoloration composition
AU5418500A (en) Troponin i composition
AU2601000A (en) Surfactant compositions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase